These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8528059)
1. The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases. Zandecki M; Facon T; Preudhomme C; Vanrumbeke M; Vachee A; Quesnel B; Lai JL; Cosson A; Fenaux P Leuk Lymphoma; 1995 Aug; 18(5-6):497-503. PubMed ID: 8528059 [TBL] [Abstract][Full Text] [Related]
2. Deletion of the retinoblastoma gene in multiple myeloma. Dao DD; Sawyer JR; Epstein J; Hoover RG; Barlogie B; Tricot G Leukemia; 1994 Aug; 8(8):1280-4. PubMed ID: 8057662 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. Preudhomme C; Vachee A; Lepelley P; Vanrumbeke M; Zandecki M; Quesnel B; Cosson A; Fenaux P Br J Haematol; 1994 May; 87(1):61-7. PubMed ID: 7524620 [TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma susceptibility gene RB-1 in multiple myeloma. Juge-Morineau N; Harousseau JL; Amiot M; Bataille R Leuk Lymphoma; 1997 Jan; 24(3-4):229-37. PubMed ID: 9156653 [TBL] [Abstract][Full Text] [Related]
5. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905 [TBL] [Abstract][Full Text] [Related]
9. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583 [TBL] [Abstract][Full Text] [Related]
10. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel mutations in the RB1 gene in Mexican patients with retinoblastoma. Rodríguez M; Salcedo M; González M; Coral-Vazquez R; Salamanca F; Arenas D Cancer Genet Cytogenet; 2002 Oct; 138(1):27-31. PubMed ID: 12419581 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702 [TBL] [Abstract][Full Text] [Related]
13. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005 [TBL] [Abstract][Full Text] [Related]
14. The retinoblastoma gene is involved in malignant progression of astrocytomas. Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217 [TBL] [Abstract][Full Text] [Related]
15. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Lai S; Benedict WF; Silver SA; El-Naggar AK Hum Pathol; 1997 Jun; 28(6):693-7. PubMed ID: 9191003 [TBL] [Abstract][Full Text] [Related]
16. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells. Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466 [TBL] [Abstract][Full Text] [Related]
17. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510 [TBL] [Abstract][Full Text] [Related]
18. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038 [TBL] [Abstract][Full Text] [Related]
20. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors. Woloschak M; Yu A; Xiao J; Post KD Int J Cancer; 1996 Jul; 67(1):16-9. PubMed ID: 8690518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]